Published by
@ShahidNShah
@ShahidNShah
ArteraAI pioneers AI-driven precision therapy in cancer care, leveraging prostate cancer biomarkers for enhanced clinical decisions. By harnessing extensive clinical data and digital pathology images, our unique MMAI architecture predicts therapeutic benefits beyond conventional methods. With potential applications across various cancers, ArteraAI aims to enable global access to personalized treatment through AI biomarker tests, supported by growing digital histopathology adoption.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 26, 2024 at 6:14am